Pegylated liposomal doxorubicin-induced hand-foot syndrome in a patient with breast cancer: Case report and FAERS database analysis
Int. Journal of Clinical Pharmacology and Therapeutics · 01.01.2026 · 64 (01) · 32-37
DOI: 10.5414/cp204868 ↗Kurz gefasst
Fallbericht in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.01.2026. Verfasst von Kejun Qu und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Antibiotics, Antineoplastic, Breast Neoplasms, Doxorubicin, Hand-Foot Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Qu, K., Zhao, J., Zhang, Y., & Li, J. (2026). Pegylated liposomal doxorubicin-induced hand-foot syndrome in a patient with breast cancer: Case report and FAERS database analysis. Int. Journal of Clinical Pharmacology and Therapeutics, 64(01), 32-37. https://doi.org/10.5414/cp204868
Vancouver
Qu K, Zhao J, Zhang Y, Li J. Pegylated liposomal doxorubicin-induced hand-foot syndrome in a patient with breast cancer: Case report and FAERS database analysis. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(01):32-37. doi:10.5414/cp204868
BibTeX
@article{Qu2026,
author = {Qu, Kejun and Zhao, Jialan and Zhang, Yongli and Li, Junwei},
title = {Pegylated liposomal doxorubicin-induced hand-foot syndrome in a patient with breast cancer: Case report and FAERS database analysis},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {64},
number = {01},
pages = {32--37},
doi = {10.5414/cp204868}
}
EUVIMED